TLDR The "After Minoxidil" spray makes hair easier to style, less greasy, and encourages people to keep using the treatment.
In 2020, a study involving 20 female patients with female pattern hair loss (FPHL) tested a new "After Minoxidil" spray designed to remove residual minoxidil from hair, aiming to improve its cosmetic properties and patient compliance. The spray restored ease of styling and reduced greasiness to preminoxidil levels in 65% and 85% of subjects, respectively, with an average greasiness reduction of 78%. Notably, 70% of subjects were likely to continue using the minoxidil and "After Minoxidil" treatment regimen for 6 months, compared to none willing to use minoxidil alone. The study concluded that the "After Minoxidil" spray improved hair styling ease and reduced greasiness after applying topical minoxidil, potentially enhancing drug compliance and efficacy.
33 citations,
October 2016 in “European Journal of Pharmaceutical Sciences” Effervescent formulations may improve minoxidil delivery, increasing effectiveness and reducing applications needed.
142 citations,
August 2007 in “Journal of The American Academy of Dermatology” New 5% minoxidil foam effectively promotes hair growth and is safe for use.
193 citations,
August 2005 in “Journal of Investigative Dermatology Symposium Proceedings” Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.
1 citations,
October 2022 in “PubMed” Patients generally have positive attitudes towards using topical Minoxidil for hair loss treatment.
3 citations,
January 2018 A woman had an unusual allergic reaction to a hair loss treatment, which cleared up after stopping the treatment and using a different medication.
14 citations,
January 2015 in “Skin appendage disorders” Minoxidil treatment for hair loss can cause scalp allergy and severe hair loss.
71 citations,
December 2013 in “The journal of investigative dermatology. Symposium proceedings/The Journal of investigative dermatology symposium proceedings” There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.
7 citations,
January 2009 in “International Journal of Trichology” Dermoscopy can't help doctors identify scalp irritation caused by topical minoxidil.
72 citations,
January 2001 in “Drugs” Minoxidil and finasteride treat hair loss; more research needed for other options.
June 1996 in “Archives of Dermatology” Minoxidil, tretinoin, and finasteride may help hair regrowth in mild to moderate androgenetic alopecia.
